Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Cash Flow Quality Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow Quality Index of 0.49x as of September 2025. Operating cash flow of CN¥110.78 Million is below net income of CN¥224.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 600329 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Quality Index (2001–2024)
Historical Cash Flow Quality Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Tianjin Zhongxin Pharmaceutical Group Co to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year earnings quality comparison for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For live market cap and the full company financial profile, see 600329 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | CN¥924.67 Million | CN¥2.22 Billion | ▼ -41.3% |
| 2023 | 0.71x | CN¥688.49 Million | CN¥968.71 Million | ▼ -8.4% |
| 2022 | 0.78x | CN¥677.25 Million | CN¥873.26 Million | ▼ -28.4% |
| 2021 | 1.08x | CN¥852.40 Million | CN¥786.88 Million | ▲ +9.7% |
| 2020 | 0.99x | CN¥671.42 Million | CN¥679.66 Million | ▲ +26.7% |
| 2019 | 0.78x | CN¥495.49 Million | CN¥635.36 Million | ▲ +26.5% |
| 2018 | 0.62x | CN¥350.14 Million | CN¥567.79 Million | ▲ +7446.5% |
| 2017 | -0.01x | CN¥-3.97 Million | CN¥473.26 Million | ▼ -100.8% |
| 2016 | 1.03x | CN¥419.90 Million | CN¥407.61 Million | ▲ +30.8% |
| 2015 | 0.79x | CN¥360.58 Million | CN¥457.87 Million | ▲ +4.2% |
| 2014 | 0.76x | CN¥286.85 Million | CN¥379.44 Million | ▲ +27.7% |
| 2013 | 0.59x | CN¥213.44 Million | CN¥360.59 Million | ▲ +1203.6% |
| 2012 | 0.05x | CN¥20.81 Million | CN¥458.29 Million | ▼ -93.0% |
| 2011 | 0.65x | CN¥173.88 Million | CN¥266.59 Million | ▲ +50.5% |
| 2010 | 0.43x | CN¥139.04 Million | CN¥320.84 Million | ▲ +42.8% |
| 2009 | 0.30x | CN¥83.41 Million | CN¥274.91 Million | ▼ -61.4% |
| 2008 | 0.79x | CN¥155.77 Million | CN¥198.22 Million | ▼ -72.0% |
| 2005 | 2.81x | CN¥261.91 Million | CN¥93.21 Million | ▲ +2146.3% |
| 2004 | 0.13x | CN¥10.50 Million | CN¥83.91 Million | ▼ -82.8% |
| 2003 | 0.73x | CN¥76.57 Million | CN¥105.15 Million | ▼ -63.5% |
| 2002 | 2.00x | CN¥187.60 Million | CN¥93.98 Million | ▼ -6.8% |
| 2001 | 2.14x | CN¥157.73 Million | CN¥73.65 Million | — |